TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biovica International AB
Closing information (x1000 NOK)
| Closing information | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Turnover |
1,950
|
2,033 | |
| Financial expenses |
75
|
59 | |
| Earnings before taxes |
-57,203
|
-38,556 | |
| EBITDA |
-51,169
|
-33,322 | |
| Total assets |
144,585
|
188,591 | |
| Current assets |
90,504
|
144,163 | |
| Current liabilities |
15,346
|
8,414 | |
| Equity capital |
118,322
|
178,812 | |
| - share capital |
1,811
|
1,539 | |
| Employees (average) |
31
|
25
|
20 |
Financial ratios
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Solvency |
81.8%
|
94.8% | |
| Turnover per employee |
78
|
102 | |
| Profit as a percentage of turnover |
-2933.5%
|
-1896.5% | |
| Return on assets (ROA) |
-39.5%
|
-20.4% | |
| Current ratio |
589.8%
|
1713.4% | |
| Return on equity (ROE) |
-48.3%
|
-21.6% | |
| Change turnover |
-31
|
397 | |
| Change turnover % |
65%
|
-2%
|
24% |
| Chg. No. of employees |
6
|
5
|
3 |
| Chg. No. of employees % |
24%
|
25%
|
18% |
Total value of public sale
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.